GRK6 and Parkinson disease: Since we found that both GRK6 and CK2α could be S-nitrosylated in vitro and in vivo, we decided to determine if increased S-nitrosylation of them could be observed in a well-characterized A53T α-syn transgenic mouse model of PD [41].